Kolexia
Chapuis Nicolas
Pharmacien
Hôpital Cochin
Paris, France
132 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Syndromes myélodysplasiques Leucémie myéloïde COVID-19 Lymphomes Inflammation Tumeurs hématologiques Myélome multiple

Industries

Novartis
2 collaboration(s)
Dernière en 2020
PASCALEO
2 collaboration(s)
Dernière en 2022
Alexion
1 collaboration(s)
Dernière en 2021
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

White blood cells scattergram as a valuable tool for COVID-19 screening: A multicentric study.
International journal of laboratory hematology   04 mars 2024
Along with PaO2/FiO2 ratio and lymphopenia, low HLA-DR monocytes are the only additional parameter that independently predicts the clinical course of undifferentiated SARS-CoV-2 patients in Emergency Departments.
Journal of leukocyte biology   15 février 2024
Enhanced fetal hematopoiesis in response to symptomatic SARS-CoV-2 infection during pregnancy.
Communications medicine   11 décembre 2023
Impact of Mutational Burden and IPSS-M on Response to ESAs in Lower Risk Myelodysplastic Neoplasms
65th ASH Annual Meeting Abstracts   02 novembre 2023
Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis.
Clinical pharmacology and therapeutics   05 octobre 2023
Subcutaneous azacitidine maintenance in transplantineligible patients with acute myeloid leukemia: a single-center retrospective study.
Haematologica   01 octobre 2023
Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry.
Haematologica   01 septembre 2023
Pathophysiology of myelodysplastic syndromes.
Bulletin du cancer   07 juillet 2023
Topic: AS01-Diagnosis/AS01b-Flow cytometry: COMMITTED AND IMMATURE ERYTHROID PROGENITORS ARE DIFFERENTLY DISTRIBUTED IN LOWER RISK MYELODYSPLASTIC SYNDROMES ACCORDING TO WHO CATEGORY AND CORRELATE WITH RESPONSE TO ERYTHROPOIESIS STIMULATING AGENTS
The 17th International Congress on Myelodysplastic Syndromes   01 mai 2023
Topic: AS04-MDS Biology and Pathogenesis/AS04e-Spliceosome machinery: DNA REPLICATION STRESS DUE TO LOSS OF R-LOOPS IN MYELODYSPLASTIC SYNDROMES WITH SF3B1 MUTATION
The 17th International Congress on Myelodysplastic Syndromes   01 mai 2023